Cargando…
Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells
Doxorubicin (Dox) is a commonly used chemotherapeutic drug in human colon cancer. However, it becomes increasingly ineffective with tumor progression, the underlying mechanism of which remains to be elucidated. Emerging evidence has led to the identification of an association between chemoresistance...
Autores principales: | LI, JINPENG, LIU, HAO, YU, JIEPING, YU, HONGGANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438913/ https://www.ncbi.nlm.nih.gov/pubmed/25684678 http://dx.doi.org/10.3892/mmr.2015.3356 |
Ejemplares similares
-
Peroxiredoxin-6 regulates p38-mediated epithelial–mesenchymal transition in HCT116 colon cancer cells
por: Chae, Unbin, et al.
Publicado: (2021) -
Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial–Mesenchymal Transition
por: Huang, Yu-Han, et al.
Publicado: (2023) -
Tetrandrine Inhibits Epithelial-Mesenchymal Transition in IL-6-Induced HCT116 Human Colorectal Cancer Cells
por: Tsai, Shih-Chang, et al.
Publicado: (2021) -
The effect of Annexin A5 overexpression on invasiveness and expression of the genes involved in epithelial-mesenchymal transition of HCT 116 cell line
por: Zamani, Bahareh, et al.
Publicado: (2023) -
Coptidis Rhizoma Suppresses Metastatic Behavior by Inhibiting TGF-β-Mediated Epithelial-Mesenchymal Transition in 5-FU-Resistant HCT116 Cells
por: Kang, Yong-Hwi, et al.
Publicado: (2022)